Furthermore, a recent genome-wide analysis for psoriasis susceptibility loci revealed an association of psoriasis with IL-12, IL-23 and NF-κB-dependent pathways [20], stressing the potential value of our recent approach by targeting NF-κB activation for the treatment of psoriasis [21]. This evidence concerns the gene IL37 and psoriasis.